SYNTHESIS OF NOVEL HMG-COA REDUCTASE INHIBITORS .1. NAPHTHALENE ANALOGS OF MEVINOLIN

被引：0

作者：

NOVAK, L

ROHALY, J

POPPE, L

HORNYANSZKY, G

KOLONITS, P

ZELEI, I

FEHER, I

FEKETE, J

SZABO, E

ZAHORSZKY, U

JAVOR, A

SZANTAY, C

机构：

[1] TECH UNIV BUDAPEST, INST ORGAN CHEM, SZT GELLERT TER 4, H-1521 BUDAPEST, HUNGARY

[2] HUNGARIAN ACAD SCI, CENT RES INST CHEM, H-1525 BUDAPEST, HUNGARY

[3] TECH UNIV BUDAPEST, INST GEN & ANALYT CHEM, H-1521 BUDAPEST, HUNGARY

[4] UNIV KARLSRUHE, INST ORGAN CHEM, W-7500 KARLSRUHE 1, GERMANY

[5] GEDEON RICHTER CHEM WORKS LTD, H-1103 BUDAPEST, HUNGARY

来源：

LIEBIGS ANNALEN DER CHEMIE | 1992年 / 02期

关键词：

HMG-COA REDUCTASE INHIBITORS; NAPHTHYLACETATES; PIG LIVER ESTERASE; GLUTARATE; 3-HYDROXY; LACTONES;

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

The title compounds 2 and their corresponding (6S) epimers 18 are prepared in several steps by starting with chiral formyl ester 5, and alpha-tetralones 10: (1) coupling reaction with the ylide generated from 11 to yield unsaturated ester 13, (2) reduction to the corresponding alcohol 14, (3) addition of the Grignard reagent derived from 14 to formyl ester 5 to afford the hydroxy esters 16 and 17, and (4) lactonization. This procedure is also used to synthesize the beta-naphthyl analogs 29 and 30. Some results obtained from HMG-CoA reductase inhibitor screening are also reported.

引用

页码：145 / 157

页数：13

共 50 条

[21] Treatment with HMG-CoA reductase inhibitors - More than lipid lowering?
Weizel, A
HERZ, 1999, 24 (01) : 42 - 50
[22] The Effectiveness of Concomitant Use of Hmg-Coa Reductase Inhibitors and Endothelial Protectors
Denisyuk, Tatyana A.
BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2019, 12 (05): : 33 - 36
[23] EFFECTS OF HMG-COA REDUCTASE INHIBITORS ON SKELETAL-MUSCLES OF RABBITS
FUKAMI, M
MAEDA, N
FUKUSHIGE, J
KOGURE, Y
SHIMADA, Y
OGAWA, T
TSUJITA, Y
RESEARCH IN EXPERIMENTAL MEDICINE, 1993, 193 (05) : 263 - 273
[24] EXTENDED WORLDWIDE EXPERIENCE HMG-COA REDUCTASE INHIBITORS LOVASTATIN AND SIMVASTATIN
MANTELL, G
THERAPIE, 1992, 47 (02): : 161 - 164
[25] Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors
Lee, Chong-Ki
Choi, Jun-Shik
Choi, Dong-Hyun
PHARMACOLOGICAL REPORTS, 2015, 67 (01) : 44 - 51
[26] Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors
Chong-Ki Lee
Jun-Shik Choi
Dong-Hyun Choi
Pharmacological Reports, 2015, 67 : 44 - 51
[27] The Safety of HMG-CoA Reductase Inhibitors in Special Populations at High Cardiovascular Risk
Alberto Corsini
Cardiovascular Drugs and Therapy, 2003, 17 : 265 - 285
[28] Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer
Solanki, Abhishek A.
Liauw, Stanley L.
RESEARCH AND REPORTS IN UROLOGY, 2011, 3 : 95 - 104
[29] Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors
Kubota, T
Fujisaki, K
Itoh, Y
Yano, T
Sendo, T
Oishi, R
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (12) : 2175 - 2186
[30] The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk
Corsini, A
CARDIOVASCULAR DRUGS AND THERAPY, 2003, 17 (03) : 265 - 285

← 1 2 3 4 5 →